Harbor UCLA Medical Center, Department of Medicine, Torrance, CA, USA
Original Research Article
Integrated Molecular Pathology as a Predictor of Malignant Transformation of Pancreatic Cysts with up to 11-Year Follow-Up
Author(s): Matthew T Bell*, Kenneth Chow, Jeremy Feng, Sofiya Reicher and Viktor E Eysselein
Background and Study Aims The 2018 ACG guidelines recommend surgical evaluation for pancreatic cysts with high-risk features. Integrated Molecular Pathology (IMP) combines molecular and biochemical analysis with cytology to assess malignant potential of pancreatic cysts. We aim to characterize the long-term diagnostic utility of IMP for pancreatic cysts. Patients and Methods Pancreatic cystic lesions from prospective patients with EUS-FNA and IMP (PancraGEN, Interpace Diagnostics) from 9/2010 to 9/2013 were retrospectively analyzed in this study for maximum 11 years of follow-up. Data on patient demographics, EUS and cross-secti.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 